메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
저널정보
대한산부인과학회 Obstetrics & Gynecology Science Obstetrics & Gynecology Science 제57권 제6호
발행연도
2014.1
수록면
457 - 463 (7page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
ObjectiveThrombocytosis is an adverse prognostic factor in many types of cancer. We investigated if pre-treatment increased platelet counts provide prognostic information specifically in patients with stage III and IV serous ovarian cancer which is the most common clinical presentation of ovarian cancer. MethodsPlatelet number on diagnosis of stage III and IV serous ovarian adenocarcinoma was evaluated in 91 patients for whom there were complete follow-up data on progression and survival. Survival and progression free survival of patients with normal platelet counts (150–350 ×109/L) was compared with that of patients with thrombocytosis (>350 ×109/L) by X2 and logrank tests. ResultsThe median age of the patients was 66 years-old. From the 91 patients, 52 (57.1%) had normal platelet counts (median, 273 ×109/L; range, 153–350) at diagnosis of their disease and 39 patients (42.9%) had thrombocytosis (median, 463 ×109/L; range, 354–631). In the group of patients with normal platelet counts, 24 of the 52 patients had died with a median survival of 43 months (range, 3–100). In the group of patients with thrombocytosis, 24 of the 39 patients had died with a median survival of 23 months (range, 4–79). In the entire group of 91 patients there was a statistically significant difference of the overall survival and progression-free survival between the two groups (logrank test P=0.02 and P=0.007, respectively). ConclusionIn this retrospective analysis of stage III and IV ovarian cancer patients, thrombocytosis at the time of diagnosis had prognostic value regarding overall survival and progression-free survival.

목차

등록된 정보가 없습니다.

참고문헌 (26)

참고문헌 신청

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0